Cardiologs puts its AI model up against the Apple Watch—and wins
Cardiologs, a Paris-based healthcare technology company, has announced that its own AI model can detect atrial arrhythmias (AAs) better than the Apple Watch’s electrocardiogram (ECG) algorithm. The company presented its data, based on a small clinical trial, Saturday, Nov. 13, at American Heart Association (AHA) Scientific Sessions 2021.
The analysis put a deep neural network (DNN) designed by Cardiologs up against the Apple Watch. Overall, Cardiologs announced, its DNN improved sensitivity by 34% and resulted in fewer unclassified readings.
“Cardiac monitoring is almost a standard feature of modern wearables like the Apple Watch, but there are still opportunities to improve ECG analysis to get a more accurate diagnosis,” Yann Fleureau, Cardiologs CEO and co-founder, said in a prepared statement. “It’s exciting to see that our deep learning algorithm can provide a more precise reading, promising many benefits for both patients and healthcare professionals. This advance will no doubt clear the path for the next generation of wearable health technology.”
In related news, Royal Philips recently announced that it has entered into an agreement to acquire Cardiologs. No financial details have been announced at this time.
More information on AHA Scientific Sessions 2021 can be found here.
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.